RedHill Biopharma expands manufacturing capacity of Covid-19 drug candidate opaganib in US

RedHill Biopharma has forged partnerships with a couple of US-based manufacturers for large-scale manufacturing of opaganib, its Covid-19 drug candidate. The Israeli biopharma company said ... Read More